RIPASA Score Calculator – Acute Appendicitis Diagnostic Assessment
Clinical Assessment
Enter the patient's demographic, symptom, examination, and laboratory findings.
A score ≥7.5 is the commonly reported positive threshold. Diagnostic performance varies across populations and study settings; use clinical assessment, laboratory findings, imaging, and surgical review as appropriate.
About the RIPASA Score
The Raja Isteri Pengiran Anak Saleha Appendicitis (RIPASA) score is a clinical scoring system developed to support the assessment of suspected acute appendicitis. Its original derivation study used 15 parameters in patients undergoing emergency appendicectomy.
Scoring components
| Parameter | Criterion | Points |
|---|---|---|
| Age | ≤40 years / >40 years | 1 / 0.5 |
| Sex | Male / Female | 1 / 0.5 |
| RIF pain | Present | 0.5 |
| Migration of pain | To RIF | 0.5 |
| Nausea or vomiting | Present | 1 |
| Anorexia | Present | 1 |
| Symptom duration | ≤48 h / >48 h | 1 / 0.5 |
| RIF tenderness | Present | 1 |
| Guarding | Present | 2 |
| Rebound tenderness | Present | 1 |
| Rovsing’s sign | Present | 2 |
| Fever | Present | 1 |
| Raised WBC count | Above local reference range | 1 |
| Negative urinalysis | Present | 1 |
| Foreign national registration identity card | Present (original setting-specific variable) | 1 |
Interpretation
<7.5: Below the commonly used positive threshold. This does not rule out acute appendicitis.
≥7.5: Positive threshold associated with increased likelihood of acute appendicitis; further clinical evaluation is required.
The original study reported a threshold of 7.5. The exact handling of age 40 and symptom duration 48 hours is not explicit in the original abstract; this calculator uses ≤40 years and ≤48 hours as operational conventions consistent with a contemporary clinical summary.
Evidence and Limitations
The original score was derived retrospectively in a single regional cohort. Its performance should not be assumed to transfer unchanged to every healthcare setting.
- The foreign national registration identity card item is specific to the original population context and is not a clinical sign. For patients outside that context, mark it “Not applicable”; interpret the resulting score cautiously.
- Meta-analyses report high pooled sensitivity but moderate specificity, with substantial between-study heterogeneity.
- The 2025 WSES Jerusalem guideline suggests AIR, AAS, and PAS for risk stratification; RIPASA is not among the scores named in that recommendation.
- Fever and raised WBC are entered as documented clinical/laboratory findings. Follow local definitions and reference intervals; the original abstract does not provide a universal numeric threshold for these items.
Selected references
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.